Short answer
Taysha Gene Therapies, Inc. (TSHA) filed an 8-K current report with the SEC on March 19, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Item 2.02 references an earnings release or financial report included as Exhibit 99.1.
Taysha Gene Therapies, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Item 2.02 references an earnings release or financial report included as Exhibit 99.1
- Filing clarifies the 8-K is furnished, not filed, limiting liability under Exchange Act Section 18
- Investors should review Exhibit 99.1 for detailed financials and performance for the relevant period
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Taysha Gene Therapies, Inc. 8-K filings
Get the next TSHA 8-K as it lands
Follow TSHA for push alerts, or ask the research agent what this filing means.